Paydas, S. 2014. Dasatinib, large granular lymphocytosis, and pleural effusion: Useful or adverse effect?. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.89, no.2 , 242-247.

Paydas, S., (2014). Dasatinib, large granular lymphocytosis, and pleural effusion: Useful or adverse effect?. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.89, no.2, 242-247.

Paydas, SEMRA. "Dasatinib, large granular lymphocytosis, and pleural effusion: Useful or adverse effect?," CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.89, no.2, 242-247, 2014

Paydas, SEMRA. "Dasatinib, large granular lymphocytosis, and pleural effusion: Useful or adverse effect?." CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.89, no.2, pp.242-247, 2014

Paydas, S. (2014) . "Dasatinib, large granular lymphocytosis, and pleural effusion: Useful or adverse effect?." CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.89, no.2, pp.242-247.

@article{article, author={SEMRA PAYDAŞ}, title={Dasatinib, large granular lymphocytosis, and pleural effusion: Useful or adverse effect?}, journal={CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY}, year=2014, pages={242-247} }